In addition to glycation, albumin, one of the most abundant circulating proteins, can also undergo a series of chemical modifications targeting the N-terminal sequence in the presence of ischemic conditions, which lead to the formation of ischemia-modified albumin (IMA) [25]. This evidence concerns the gene ALB and ischemia.